Multimodal Pain Control Reduces Narcotic Use after Outpatient Abdominoplasty: Retrospective Analysis in an Ambulatory Surgery Practice
- PMID: 36699223
- PMCID: PMC9870214
- DOI: 10.1097/GOX.0000000000004777
Multimodal Pain Control Reduces Narcotic Use after Outpatient Abdominoplasty: Retrospective Analysis in an Ambulatory Surgery Practice
Abstract
Despite dominating fewer headlines, the opioid epidemic continues to plague society. Surgeons have the responsibility to change their opioid prescribing habits while maintaining adequate patient comfort. This study examines the transition to a multimodal, perioperative protocol in an ambulatory surgery setting for abdominoplasty patients. We hypothesized that using multimodal analgesia could significantly reduce narcotic consumption.
Methods: The authors retrospectively compared one surgeon's consecutive abdominoplasty patients over 24 months. The control group received primarily narcotic medications to manage pain, and the treatment cohort was given a multimodal protocol for perioperative analgesia.
Results: Demographic data, surgical time, and postanesthesia care unit time between the groups were similar. Although the mean intravenous narcotic decreased in the operating room and postanesthesia care unit for the treatment group, it failed to achieve statistical significance. The treatment cohort was prescribed two-thirds less oral narcotic than the control (251 versus 787 mean morphine milligram equivalents P < 0.001). Ten patients in the treatment cohort used no oral narcotics compared to one in the control (P = 0.002), and only four narcotic refills were given in the treatment group compared to 36 in the control (P < 0.001), suggesting that the treatment group had better pain control despite taking fewer narcotics.
Conclusions: Optimally utilizing multimodal medications effectively reduces narcotic consumption while effectively managing postoperative pain from abdominoplasty in a private practice, ambulatory surgery setting. Surgeons must change their prescribing habits if we are going to make progress in the war against the opioid crisis.
Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.
Conflict of interest statement
Disclosure: The authors have no financial interest to declare in relation to the content of this article.
Figures
References
-
- Crystal DT, Blankensteijn LL, Ibrahim AMS, et al. . Quantifying the crisis: opioid-related adverse events in outpatient ambulatory plastic surgery. Plast Reconstr Surg. 2020;145:687–695. - PubMed
-
- Gan TJ, Habib AS, Miller TE, et al. . Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey. Curr Med Res Opin. 2014;30:149–160. - PubMed
-
- Apfelbaum JL, Chen C, Mehta SS, et al. . Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003;97:534–540. - PubMed
-
- O’Brien AL, Krasniak PJ, Schroeder MJ, et al. . Impact of opioid restriction legislation on prescribing practices for outpatient plastic and reconstructive surgery. Plast Reconstr Surg. 2022;150:213–221. - PubMed
LinkOut - more resources
Full Text Sources